Injective (INJ) is currently trading at $3.12, reflecting a 4.86% increase over the past 24 hours. The daily price range has been relatively narrow, with a high of $3.13 and a low of $2.95, indicating a stable trading environment despite recent fluctuations.

The trading volume stands at approximately 40.88 million, contributing to a market cap ratio of 13.13%, which suggests a healthy trading activity relative to market capitalization. The hourly moving averages show a mixed picture, with shorter-term averages indicating positive momentum while the 144 SMA reflects a slight downward trend, suggesting potential resistance at $3.15.

The 1-hour RSI is currently at 76, indicating overbought conditions, which could lead to a short-term pullback. Conversely, the 7-day RSI at 49 suggests that the asset is in neutral territory over the longer term, indicating potential for recovery if buying momentum can sustain.

Over the past week, INJ has decreased by nearly 9.89%, and the 14-day and 30-day changes are significantly more negative at -28.13% and -39.99%, respectively. This suggests that while there is short-term positive momentum, the longer-term trend is still bearish, raising concerns about the sustainability of current gains.

Given the current price action, the market's mixed signals, and the longer-term downtrend, a cautious approach is warranted. Therefore, the recommendation is to Hold INJ at this time, as potential profit-taking could occur in the short term while watching for signs of a more sustained upward movement before considering a Buy.